Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NEUP compared with IGC: revenue, margins and what each company keeps, and the suppliers and customers both name
NEUP
Neuphoria Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
IGC
IGC Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NEUP
Neuphoria Therapeutics Inc.
vs
IGC
IGC Pharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
NEUP
Neuphoria Therapeutics Inc.
Change
3.03
▲
+1.34%
· post 3.00
· delayed
Mkt cap
$16.2M
Revenue
$15M
Q3 FY25
Revenue
—
IGC
IGC Pharma, Inc.
Change
0.19
▲
+4.25%
· post 0.20
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$18.7M
Revenue
$265,000
Q2 FY26
Revenue
$1M
FY25
vs
Compare
After hours
Nov 4 '26
delayed
NEUP
Neuphoria Therapeutics Inc.
vs
IGC
IGC Pharma, Inc.
3.03
▲
+1.34%
post 3.00
delayed
Price
0.19
▲
+4.25%
post 0.20
delayed
$16.2M
Mkt cap
$18.7M
Q3 FY25
$15M
Revenue
$265,000
Q2 FY26
—
Revenue
$1M
FY25
Change
Change
NEUP
3.03
▲
+1.34%
vs
IGC
0.19
▲
+4.25%
After hours
Nov 4 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
IGC: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NEUP
6
MRK
Merck
customer
—
Danforth Advisors
unlisted
supplier
—
Wolf & Company, P.C
unlisted
supplier
—
WG Partners LLP
unlisted
supplier
2 more · NEUP chain
›
Shared
0
No disclosed counterparties: IGC.
Only IGC
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NEUP, solid
IGC, dashed